Search Results - Pengpeng Qu
- Showing 1 - 20 results of 20
-
1
-
2
CS Ratio is an immune-related prognostic biomarker for cervical cancer by Peiqin Shi, Wenwen Zhang, Qingqing Yao, Zhanna Yuan, Zhanna Yuan, Jiaqi Wang, Ziye Yang, Pengpeng Qu, Pengpeng Qu, Pengpeng Qu
Published in Frontiers in Oncology (2025-08-01)Get full text
Article -
3
Peutz-Jeghers syndrome with gastric-type mucinous endocervical adenocarcinoma and sex-cord tumor with annular tubules: A case report by Xuanyan Li, Xuanyan Li, Yue Qi, Yue Qi, Wenwen Zhang, Yang Rao, Na Zhang, Pengpeng Qu, Pengpeng Qu, Pengpeng Qu
Published in Frontiers in Medicine (2023-03-01)Get full text
Article -
4
Correction: CS Ratio is an immune-related prognostic biomarker for cervical cancer by Peiqin Shi, Wenwen Zhang, Qingqing Yao, Zhanna Yuan, Zhanna Yuan, Jiaqi Wang, Ziye Yang, Pengpeng Qu, Pengpeng Qu, Pengpeng Qu
Published in Frontiers in Oncology (2025-09-01)Get full text
Article -
5
-
6
Comparing and Evaluating Five-Day Chemotherapy Agents Actinomycin D and Methotrexate in Low-Risk Post-Molar Gestational Trophoblastic Neoplasia: A Retrospective Analysis by Juan Xu, Xinmei Wang, Pengpeng Qu
Published in Clinical and Experimental Obstetrics & Gynecology (2022-05-01)Get full text
Article -
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
HPV16 E7 oncoprotein test as a triage strategy for HPV16-positive women in cervical cancer screening: long-term follow-up outcome by Xinmei Wang, Guangnan Shuai, Junhui Xu, Meihua Liu, Meihua Liu, Jianguo Zhao, Na Zhang, Wenwen Zhang, Pengpeng Qu
Published in Frontiers in Oncology (2023-09-01)Get full text
Article -
17
A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis by Jia Li, Xuan Qin, Jie Shi, Xiaoshuang Wang, Tong Li, Mengyao Xu, Xiaosu Chen, Yujia Zhao, Jiahao Han, Yongjun Piao, Wenwen Zhang, Pengpeng Qu, Longlong Wang, Rong Xiang, Yi Shi
Published in eLife (2021-06-01)Get full text
Article -
18
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer by Zhen Yuan, Ying Zhang, Dongyan Cao, Keng Shen, Qingshui Li, Guonan Zhang, Xiaohua Wu, Manhua Cui, Ying Yue, Wenjun Cheng, Li Wang, Pengpeng Qu, Guangshi Tao, Jianqing Hou, Lixin Sun, Yuanguang Meng, Guiling Li, Changzhong Li, Huirong Shi, Yaqing Chen
Published in Journal of Ovarian Research (2021-01-01)Get full text
Article -
19
Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer by Huayi Li, Zikun Peng, Jianqing Zhu, Weidong Zhao, Yi Huang, Ruifang An, Hong Zheng, Pengpeng Qu, Li Wang, Qi Zhou, Danbo Wang, Ge Lou, Jing Wang, Ke Wang, Beihua Kong, Xing Xie, Rutie Yin, John Low, Abdul Malik Rozita, Lim Chun Sen, Yong Chee Meng, Kho Swee Kiong, Jihong Liu, Zhiqing Liang, Weiguo Lv, Yaping Zhu, Weiguo Hu, Wei Sun, Jingya Su, Qiqi Wang, Rongyu Zang, Ding Ma, Qinglei Gao
Published in BMC Medicine (2024-05-01)Get full text
Article -
20
Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial by Yingjie Hu, Yingyan Han, Yuanming Shen, Jing Chen, Yaheng Chen, Yile Chen, Junying Tang, Min Xue, Li Hong, Wenjun Cheng, Danbo Wang, Zhiqing Liang, Yifeng Wang, Qinghua Zhang, Hui Xing, Yu Zhang, Cunjian Yi, Zhiying Yu, Youguo Chen, Manhua Cui, Cailing Ma, Hongying Yang, Ruizhen Li, Ping Long, Yu Zhao, Pengpeng Qu, Guangshi Tao, Lihua Yang, Sufang Wu, Zhihua Liu, Ping Yang, Weiguo Lv, Xing Xie, Ding Ma, Hui Wang, Kezhen Li
Published in BMC Cancer (2022-12-01)Get full text
Article
